These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1350670)

  • 1. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
    Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
    Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
    Donis-Keller H; Dou S; Chi D; Carlson KM; Toshima K; Lairmore TC; Howe JR; Moley JF; Goodfellow P; Wells SA
    Hum Mol Genet; 1993 Jul; 2(7):851-6. PubMed ID: 8103403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
    Mulligan LM; Kwok JB; Healey CS; Elsdon MJ; Eng C; Gardner E; Love DR; Mole SE; Moore JK; Papi L
    Nature; 1993 Jun; 363(6428):458-60. PubMed ID: 8099202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues.
    Munnes M; Patrone G; Schmitz B; Romeo G; Doerfler W
    Oncogene; 1998 Nov; 17(20):2573-83. PubMed ID: 9840920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
    Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
    Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the promoter region of the c-yes proto-oncogene: the importance of the GC boxes on its promoter activity.
    Matsuzawa Y; Semba K; Kawamura-Tsuzuku J; Sudo T; Ishii S; Toyoshima K; Yamamoto T
    Oncogene; 1991 Sep; 6(9):1561-7. PubMed ID: 1923523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
    Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
    Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
    Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
    Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene.
    Tong Q; Li Y; Smanik PA; Fithian LJ; Xing S; Mazzaferri EL; Jhiang SM
    Oncogene; 1995 May; 10(9):1781-7. PubMed ID: 7753554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
    Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
    Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
    Ikeda I; Ishizaka Y; Tahira T; Suzuki T; Onda M; Sugimura T; Nagao M
    Oncogene; 1990 Sep; 5(9):1291-6. PubMed ID: 2216455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physical map of the human RET proto-oncogene.
    Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
    Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1 and Sp3 transactivate the RET proto-oncogene promoter.
    Andrew SD; Delhanty PJ; Mulligan LM; Robinson BG
    Gene; 2000 Oct; 256(1-2):283-91. PubMed ID: 11054558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence and characterisation of the RET proto-oncogene 5' flanking region: analysis of retinoic acid responsiveness at the transcriptional level.
    Patrone G; Puliti A; Bocciardi R; Ravazzolo R; Romeo G
    FEBS Lett; 1997 Dec; 419(1):76-82. PubMed ID: 9426223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight linkage of the ret proto-oncogene with the multiple endocrine neoplasia type 2A locus.
    Yamamoto M; Miki T; Tanaka N; Miya A; Shin E; Karakawa K; Kobayashi T; Tahira T; Ishizaka Y; Itoh F
    Jpn J Clin Oncol; 1991 Jun; 21(3):149-52. PubMed ID: 1682518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
    Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
    J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.
    Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M
    Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.